These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35520391)

  • 1. RhoA-ROCK competes with YAP to regulate amoeboid breast cancer cell migration in response to lymphatic-like flow.
    Mohammadalipour A; Diaz MF; Livingston M; Ewere A; Zhou A; Horton PD; Olamigoke LT; Lamar JM; Hagan JP; Lee HJ; Wenzel PL
    FASEB Bioadv; 2022 May; 4(5):342-361. PubMed ID: 35520391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
    Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
    Debidda M; Wang L; Zang H; Poli V; Zheng Y
    J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness.
    Peng Y; Chen Z; Chen Y; Li S; Jiang Y; Yang H; Wu C; You F; Zheng C; Zhu J; Tan Y; Qin X; Liu Y
    Acta Biomater; 2019 Apr; 88():86-101. PubMed ID: 30771534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer.
    Wen X; Wan J; He Q; Wang M; Li S; Jiang M; Qian Z; Liu B; Lu W; Wang K; Gao K; Wan X
    Signal Transduct Target Ther; 2020 May; 5(1):81. PubMed ID: 32457342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells.
    Pietrovito L; Comito G; Parri M; Giannoni E; Chiarugi P; Taddei ML
    Curr Cancer Drug Targets; 2019; 19(10):807-816. PubMed ID: 30648509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
    Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
    Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FilGAP and its close relatives: a mediator of Rho-Rac antagonism that regulates cell morphology and migration.
    Nakamura F
    Biochem J; 2013 Jul; 453(1):17-25. PubMed ID: 23763313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility.
    Matsuoka T; Yashiro M; Kato Y; Shinto O; Kashiwagi S; Hirakawa K
    Clin Exp Metastasis; 2011 Oct; 28(7):627-36. PubMed ID: 21667311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases.
    Wojciak-Stothard B; Ridley AJ
    J Cell Biol; 2003 Apr; 161(2):429-39. PubMed ID: 12719476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
    Li T; Guo T; Liu H; Jiang H; Wang Y
    Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low shear stress induces ERK nuclear localization and YAP activation to control the proliferation of breast cancer cells.
    Qin X; Li J; Sun J; Liu L; Chen D; Liu Y
    Biochem Biophys Res Commun; 2019 Mar; 510(2):219-223. PubMed ID: 30685085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RHOA GTPase Controls YAP-Mediated EREG Signaling in Small Intestinal Stem Cell Maintenance.
    Liu M; Zhang Z; Sampson L; Zhou X; Nalapareddy K; Feng Y; Akunuru S; Melendez J; Davis AK; Bi F; Geiger H; Xin M; Zheng Y
    Stem Cell Reports; 2017 Dec; 9(6):1961-1975. PubMed ID: 29129684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1.
    Zhou H; Kramer RH
    J Biol Chem; 2005 Mar; 280(11):10624-35. PubMed ID: 15611088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
    Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
    Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rac1 and Cdc42 GTPases regulate shear stress-driven β-catenin signaling in osteoblasts.
    Wan Q; Cho E; Yokota H; Na S
    Biochem Biophys Res Commun; 2013 Apr; 433(4):502-7. PubMed ID: 23524265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
    Yamazaki D; Kurisu S; Takenawa T
    Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells.
    El-Sibai M; Pertz O; Pang H; Yip SC; Lorenz M; Symons M; Condeelis JS; Hahn KM; Backer JM
    Exp Cell Res; 2008 Apr; 314(7):1540-52. PubMed ID: 18316075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.